Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG666713 Inhibitors

EG666713 inhibitors are a class of chemical compounds that target the EG666713 protein, which is involved in various cellular processes. These inhibitors work by selectively binding to EG666713, thereby modulating its activity and affecting downstream signaling pathways. The structure of EG666713 inhibitors is characterized by a core scaffold that allows for specific interaction with the target protein, often involving aromatic rings, heterocyclic components, and functional groups that enhance binding affinity. This binding typically interferes with the enzymatic or regulatory function of EG666713, leading to alterations in cellular functions such as signal transduction, transcription, or other biochemical pathways. The molecular design of EG666713 inhibitors is often highly specific to optimize potency and selectivity while minimizing interactions with non-target proteins, thereby reducing off-target effects and increasing efficacy in modulating the activity of EG666713.

The chemical properties of EG666713 inhibitors, such as solubility, stability, and cell permeability, are key factors that contribute to their bioavailability and effectiveness in biological systems. These inhibitors can vary widely in their chemical nature, ranging from small molecules to larger, more complex structures, but they generally share common features that promote strong and specific binding to EG666713. Chemical modifications to the core scaffold and side chains are often employed to enhance these properties, tailoring the compounds to achieve the desired balance of potency, selectivity, and pharmacokinetic profile. Additionally, structural-activity relationship (SAR) studies are conducted to identify optimal chemical groups and configurations that enhance the interaction between the inhibitor and EG666713. By fine-tuning the chemical structure, researchers aim to produce inhibitors that are not only effective in modulating EG666713 activity but also suitable for further biological research and exploration.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Binds to actin monomers, preventing polymerization and potentially disrupting cytoskeletal interactions.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$100.00
$321.00
$2289.00
$4484.00
$18207.00
$34749.00
3
(2)

Binds tubulin, inhibiting its polymerization, potentially impacting cell division and intracellular transport.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Stabilizes microtubules, affecting cell division and intracellular dynamics, which may alter CCDC168-related processes.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Destabilizes microtubules, which can interfere with cell division and vesicle transport systems.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K, affecting signal transduction pathways linked to various cellular processes that CCDC168 may be a part of.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK, which may impact signal transduction pathways involving CCDC168.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Inhibitor of ROCK kinase, affecting cell shape, motility, and potentially protein-protein interactions.

(S)-(−)-Blebbistatin

856925-71-8sc-204253
sc-204253A
sc-204253B
sc-204253C
1 mg
5 mg
10 mg
25 mg
$72.00
$265.00
$495.00
$968.00
(2)

Inhibits myosin II, affecting cell motility and cytokinesis, which could influence CCDC168's role in these processes.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

Inhibits myosin light chain kinase, affecting cell contraction and motility.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Inhibits MEK1/2, which could alter signal transduction pathways related to CCDC168.